VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Harvard Bioscience, Inc. (HBIO) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medical Instruments & Supplies · market value about $39.5M · revenue $87.8M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows